ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…

2024 ASCO® Annual Meeting Insights Hub

L. Raez

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

NSCLC & Targeted Therapy: A Brief Overview and Update in the Metasta…

Memorial Sloan Kettering Cancer Center

M. Hwang

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

An Update on Lung Cancer Targeted Therapies: The Evolution of Person…

University of Miami Sylvester Comprehensive Cancer Center

E. Rodriguez

Diagnostics in Lung Cancer: A Comprehensive Discussion - Best of Lun…

Total Health

T. Boyle

UChicago Medicine Best of ASCO® 2024: NSCLC

UChicago Medicine Annual Practice Updates in Hematology and Oncology

R. Thawani

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics

Springer Healthcare IME

S. Peters

The Changing Prognosis of Lung Cancer Brain Metastases

MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

S. Goldberg

Biomarker Testing in NSCLC

Martin Dietrich

Progress in the Treatment of NSCLC

Yale Cancer Center

R. Herbst

Precision Medicine in NSCLC

UChicago Medicine 12th International Clinical Cancer Genomics Conference

S. Gray

Management of Stage IV NSCLC With Actionable Mutations

Integrity CE

G. Dy

Current ADC Development in NSCLC

MI&T Congressi

H. Borghaei

Options for ALK+ NSCLC

MI&T Congressi

J. Lin

WCLC 2024 Insights: Biology of CNS Metastases in NSCLC

Insights from 2024 WCLC

T. Burns

How the Experts Treat: Neoadjuvant or Adjuvant Targeted Therapy in R…

MI&T Congressi

J. Naidoo

2024 Neuro-Oncology Update: NSCLC and Brain Mets

Scripps Health

T. McGranahan

ESMO 2023 Summary: "Highlights From Recent NSCLC Trials"

ecancer

B. Gyawali

Landscape of Biomarker Testing for NSCLC

Springer Healthcare IME

F. López-Ríos